Bile Acid Inhibits Apolipoprotein A Expression in HepG2 Cells by Up-regulation of miR-23b-3p
Author:
Affiliation:

1.Department of Pathology, Linyi Women and Children Hospital, Linyi, Shandong 276000, China;2. Institute of Cardiovascular Diseases & Key Laboratory for Atherosclerology of Hunan Province, University of South China, Hengyang, Hunan 421001, China;3.Department of Function, First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China)

Clc Number:

R363

  • Article
  • | |
  • Metrics
  • |
  • Reference [11]
  • | | | |
  • Comments
    Abstract:

    Aim To analyze the relationship between the effect of bile acid reducing the level of apolipoprotein A (ApoA) and the expression of miR-23b-3p, and to find new mechanisms of bile acid reducing the level of ApoA. Methods The target genes of miR-23b-3p and transcription factor hepatocyte nuclear factor 4γ (HNF4γ) regulating the LPA gene were analyzed by bioinformatics online tools Targetscan 7.0. Luciferase reporter assay was used to test target gene relationship for miR-23b-3p. Protein expression of ApoA, mitogen-activated protein kinase (p38MAPK) and p-p38MAPK were detected by Western blot in HepG2 cells, and miR-23b-3p expression was measured by real-time quantitative polymerase chain reaction. Results Bioinformatics analysis indicated that HNF4γ could act as a target gene of miR23b-3p. The fluorescent intensity of miR-23b-3p transfection cells was significantly lower than that of control group by using luciferase report assay, and it meant that HNF4γ could act as a target gene of miR23b-3p. Bile acid restrained ApoA expression in HepG2 cells in a dose- and time-dependent manner, and 32 mg/L and 24 h were the best action dose and time. Bile acid restraining the ApoA expression was related to the activation of MAPK and the up-regulation of miR-23b-3p. Moreover, it could regulate the expressions of miR-23b-3p, farnesyl X receptor and MAPK. Conclusion Bile acid can significantly down-regulate ApoA expression in HepG2 cells by a dose- and time-dependent manner, its mechanism is related to up-regulating the expression of miR-23b-3p.

    Reference
    [1] Langer C, Tambyrayah B, Thedieck S, et al.Testing for lipoprotein(a) concentration and apolipoprotein(a) phenotypes:Method standardization and pediatric reference values.Semin Thromb Hemost, 1,7(7):810-813.
    [2] Merki E, Graham MJ, Mullick AE, et al.Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.Circulation, 8,8(7):743-753.
    [3] Koornneef A, Maczuga P, van Logtenstein R, et al.Apolipoprotein B knockdown by AAV-delivered shRNA lowers plasma cholesterol in mice.Mol Ther, 1,9(4):731-740.
    [4] Zabaneh D, Kumari M, Sandhu M, et al.Meta analysis of candidate gene variants outside the LPA locus with Lp(a) plasma levels in 14500 participants of six White European cohorts.Atherosclerosis, 1,7(2):447-451.
    [5] Chennamsetty I, Claudel T, Kostner KM, et al.Farnesoid X receptor represses hepatic human APOA gene expression.J Clin Invest, 1,1(9):3 724-734.
    [6] Puckey LH, Knight BL.Sequence and functional changes in a putative enhancer region upstream of the apolipoprotein(a) gene.Atherosclerosis, 3,6(1):119-127.
    [7] Hixson JE, Jett C, Birnbaum S.Identification of promoter sequences in the 5' untranslated region of the baboon apolipoprotein(a) gene.J Lipid Res, 6,7(11):2 324-331.
    [8] Chennamsetty I, Claudel T, Kostner KM, et al.FGF19 signaling cascade suppresses APOA gene expression.Arterioscler Thromb Vasc Biol, 2,2(5):1 220-227.
    [9] Chennamsetty I, Kostner KM, Claudel T, et al.Nicotinic acid inhibits hepatic APOA gene expression:studies in humans and in transgenic mice.J Lipid Res, 2,3(11):2 405-412.
    [10] Puckey LH, Knight BL.Interaction of oestrogen and peroxisome proliferator-activated receptors with apolipoprotein(a) gene enhancers.Biochem J, 2,6(Pt 1):157-163.
    [11] Gonzalez FJ.Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription.Drug Metab Pharmacokinet, 8,3(1):2-7.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

TIAN Yong-Feng, MO Xue-Liang, LEI Jian-Jun, LIU Ya-Mi, BAI Jie, WANG Zuo. Bile Acid Inhibits Apolipoprotein A Expression in HepG2 Cells by Up-regulation of miR-23b-3p[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(8):769-773.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 28,2015
  • Revised:December 26,2015
  • Online: July 25,2016
Article QR Code